Clinical trials · Portland, OR
Transthyretin Amyloidosis clinical trials in Portland
We’re tracking 6 recruiting transthyretin amyloidosis studies with a site in or near Portland — including Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Portland
- NCT06128629RecruitingPhase 3
A study of NTLA-2001 for transthyretin amyloidosis with heart problems
This study tests a new treatment, NTLA-2001, for people with a type of heart disease called transthyretin amyloidosis with cardiomyopathy. It aims to see if the medicine can help improve heart function and quality of life.
Portland, OregonAges 18–90 - NCT06465810Recruiting
Observational study for ATTR amyloidosis patients
This study follows patients with ATTR amyloidosis over time to understand how the disease affects them. It does not test a new treatment—instead, it asks you to fill out questionnaires about your health and symptoms to help doctors learn more about the condition.
Portland, OregonAges 18–130 - NCT06563895RecruitingPhase 3
Testing acoramidis to prevent ATTR amyloidosis in gene carriers
This trial tests a daily pill called acoramidis to see if it can prevent ATTR amyloidosis in people who carry a gene mutation but have no symptoms yet. It aims to stop the disease before it starts.
Portland, OregonAges 18–75 - NCT05758493RecruitingPhase 2
Iodine-124 scan study for systemic amyloidosis
This Phase 2 study tests an iodine-based scan medicine to help learn how systemic amyloidosis affects the body and organs. It may help doctors better characterize the disease using specific imaging tests.
Portland, OregonAges 40–90 - NCT07052903RecruitingPhase 3
RNA therapy for ATTR amyloidosis with heart involvement
This trial tests an experimental RNA therapy (nucresiran) for people with transthyretin amyloidosis that causes heart problems (cardiomyopathy). It aims to lower the abnormal protein buildup to help heart function.
Portland, OregonAges 18–85 - NCT07207811RecruitingPhase 3
Coramitug for heart failure caused by ATTR amyloidosis
This trial tests a new medicine called Coramitug for people with heart failure due to ATTR amyloidosis, a condition where abnormal proteins build up in the heart. The study aims to see if Coramitug can improve heart function and quality of life.
Portland, OregonAges 18 years+
Hear when a new Transthyretin Amyloidosis trial opens near Portland, OR
We’ll email you when one opens near Portland, OR — at most once a week, no account needed, unsubscribe anytime.
Transthyretin Amyloidosis trials in other cities
Where these studies are running near Portland
Institutions with a site for the recruiting transthyretin amyloidosis studies listed above.
- Oregon Health and Science University · 4 studies
- Clinical Trial Site
- Research Site
What taking part in a transthyretin amyloidosis study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting transthyretin amyloidosis studies in Oregon.
Common questions
- Are there transthyretin amyloidosis clinical trials near Portland?
- Yes. We're currently tracking 6 recruiting transthyretin amyloidosis studies with a site near Portland, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a transthyretin amyloidosis study near Portland?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Portland to take part?
- Not necessarily. These studies have a site near Portland, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a transthyretin amyloidosis trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New transthyretin amyloidosis studies open near Portland regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.